Healthcare provider profile · identity verified

Melissa A Leedle, MD

Family Practice · CLACKAMAS, OR · NPI 1750647434

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	509	167
Levothyroxine Sodium	Levothyroxine Sodium	346	113
Losartan Potassium	Losartan Potassium	280	107
Amlodipine Besylate	Amlodipine Besylate	248	90
Lisinopril	Lisinopril	221	88
Omeprazole	Omeprazole	207	86
Metoprolol Succinate	Metoprolol Succinate	173	63
Rosuvastatin Calcium	Rosuvastatin Calcium	131	52
Duloxetine Hcl	Duloxetine Hcl	110	37
Metformin Hcl Er	Metformin Hcl	96	38
Trazodone Hcl	Trazodone Hcl	96	35
Montelukast Sodium	Montelukast Sodium	92	35
Simvastatin	Simvastatin	83	25
Gabapentin	Gabapentin	82	37
Sertraline Hcl	Sertraline Hcl	82	26
Eliquis	Apixaban	81	29
Donepezil Hcl	Donepezil Hcl	79	20
Fluticasone Propionate	Fluticasone Propionate	72	36
Pravastatin Sodium	Pravastatin Sodium	71	22
Metformin Hcl	Metformin Hcl	70	28
Furosemide	Furosemide	66	21
Pantoprazole Sodium	Pantoprazole Sodium	66	20
Albuterol Sulfate Hfa	Albuterol Sulfate	65	38
Hydrochlorothiazide	Hydrochlorothiazide	62	27
Potassium Chloride	Potassium Chloride	62	19
Citalopram Hbr	Citalopram Hydrobromide	58	18
Alendronate Sodium	Alendronate Sodium	57	25
Bupropion Xl	Bupropion Hcl	54	16
Escitalopram Oxalate	Escitalopram Oxalate	50	18
Tamsulosin Hcl	Tamsulosin Hcl	47	18
Clopidogrel	Clopidogrel Bisulfate	46	11
Glipizide	Glipizide	44	19
Memantine Hcl	Memantine Hcl	44	suppressed
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	40	12
Fluoxetine Hcl	Fluoxetine Hcl	37	12
Tizanidine Hcl	Tizanidine Hcl	36	11
Mirtazapine	Mirtazapine	35	suppressed
Estradiol	Estradiol	34	18
Paroxetine Hcl	Paroxetine Hcl	33	suppressed
Lovastatin	Lovastatin	32	12
Isosorbide Mononitrate Er	Isosorbide Mononitrate	31	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	31	suppressed
Carvedilol	Carvedilol	30	12
Ozempic	Semaglutide	29	suppressed
Xarelto	Rivaroxaban	29	suppressed
Finasteride	Finasteride	28	suppressed
Allopurinol	Allopurinol	27	suppressed
Synthroid	Levothyroxine Sodium	27	suppressed
Benazepril Hcl	Benazepril Hcl	26	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	26	17
Metoprolol Tartrate	Metoprolol Tartrate	24	suppressed
Ibandronate Sodium	Ibandronate Sodium	23	suppressed
Ipratropium Bromide	Ipratropium Bromide	22	11
Olmesartan Medoxomil	Olmesartan Medoxomil	22	11
Cephalexin	Cephalexin	21	19
Famotidine	Famotidine	21	suppressed
Ondansetron Hcl	Ondansetron Hcl	21	13
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	20	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	19	suppressed
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	18	suppressed
Nortriptyline Hcl	Nortriptyline Hcl	18	suppressed
Atenolol	Atenolol	17	suppressed
Diclofenac Sodium	Diclofenac Sodium	17	11
Glipizide Er	Glipizide	16	suppressed
Loperamide	Loperamide Hcl	16	suppressed
Oxycodone Hcl	Oxycodone Hcl	16	suppressed
Aripiprazole	Aripiprazole	15	suppressed
Breo Ellipta	Fluticasone/Vilanterol	15	suppressed
Nystatin	Nystatin	15	suppressed
Spiriva Respimat	Tiotropium Bromide	15	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	15	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	14	suppressed
Ketoconazole	Ketoconazole	14	suppressed
Lorazepam	Lorazepam	14	suppressed
Warfarin Sodium	Warfarin Sodium	14	suppressed
Latanoprost	Latanoprost	13	suppressed
Olanzapine	Olanzapine	13	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	13	suppressed
Premarin	Estrogens, Conjugated	13	suppressed
Valacyclovir	Valacyclovir Hcl	13	suppressed
Acyclovir	Acyclovir	12	suppressed
Hydralazine Hcl	Hydralazine Hcl	12	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	11	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	11	suppressed
Prednisone	Prednisone	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error